{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T07:48:24Z","timestamp":1759564104101,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.peptides.2009.11.026","type":"journal-article","created":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T09:58:03Z","timestamp":1259661483000},"page":"227-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Protease-activated receptor 2 and bradykinin-mediated vasodilation in the cerebral arteries of stroke-prone rats"],"prefix":"10.1016","volume":"31","author":[{"given":"John S.","family":"Smeda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Daneshtalab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2009.11.026_bib1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1172\/JCI200318684","article-title":"Modulation of the molecular composition of large conductance, Ca2+-activated K+ channels in vascular smooth muscle during hypertension","volume":"112","author":"Amberg","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.peptides.2009.11.026_bib2","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/00005344-200203000-00009","article-title":"Alterations of the nitric oxide pathway in cerebral arteries from spontaneously hypertensive rats","volume":"39","author":"Briones","year":"2002","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.peptides.2009.11.026_bib3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.vph.2005.07.009","article-title":"Protease-activated receptor-2 (PAR2) in cardiovascular system","volume":"43","author":"Bucci","year":"2005","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.peptides.2009.11.026_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00004872-199301000-00006","article-title":"Control of blood pressure and end-organ damage in maturing salt-loaded stroke\u2013prone spontaneously hypertensive rats by oral angiotension II receptor blockade","volume":"11","author":"Camargo","year":"1993","journal-title":"J Hypertens"},{"key":"10.1016\/j.peptides.2009.11.026_bib5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1469-7793.2001.0359i.x","article-title":"K+ currents underlying the action of endothelium-derived hyperpolarizing factor in guinea-pig, rat and human blood vessels","volume":"531","author":"Coleman","year":"2001","journal-title":"J Physiol"},{"key":"10.1016\/j.peptides.2009.11.026_bib6","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1055\/s-0037-1614574","article-title":"Increased expression of protease activated receptor-2 (PAR-2) in balloon-injured rat carotid artery","volume":"81","author":"Damiano","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.peptides.2009.11.026_bib7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/24388","article-title":"K+ is an endothelium-derived hyperpolarizing factor in rat arteries","volume":"396","author":"Edwards","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2009.11.026_bib8","first-page":"H2060","article-title":"Impaired endothelium-mediated relaxation in isolated cerebral arteries from insulin-resistant rats","volume":"282","author":"Erdos","year":"2002","journal-title":"Am J Physiol"},{"key":"10.1016\/j.peptides.2009.11.026_bib9","first-page":"S61","article-title":"Myogenic mechanisms in the cerebral circulation","volume":"7","author":"Faraci","year":"1989","journal-title":"J Hypertens"},{"key":"10.1016\/j.peptides.2009.11.026_bib10","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1440-1681.2002.03689.x","article-title":"Critical role of gap junctions in endothelium-dependent hyperpolarization in rat mesenteric arteries","volume":"29","author":"Goto","year":"2002","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.peptides.2009.11.026_bib11","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/sj.bjp.0705698","article-title":"Endothelium-dependent smooth muscle hyperpolarization: do gap junctions provide a unifying hypothesis?","volume":"141","author":"Griffith","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.peptides.2009.11.026_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1254\/jphs.FMJ04005X3","article-title":"Physiology and pathophysiology of proteinase-activated receptors (PARs): role of tryptase\/PAR2 in vascular endothelial barrier function","volume":"97","author":"Itoh","year":"2005","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.peptides.2009.11.026_bib13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/sj.bjp.0702063","article-title":"Increased vascular permeability by a specific agonist of protease-activated receptor-2 in rat hindpaw","volume":"125","author":"Kawabata","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.peptides.2009.11.026_bib14","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.cardiores.2003.11.030","article-title":"Distinct roles for protease-activated receptors 1 and 2 in vasomotor modulation in rat superior mesenteric artery","volume":"61","author":"Kawabata","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.peptides.2009.11.026_bib15","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/j.lfs.2004.07.006","article-title":"Receptor-activating peptides for PAR-1 and PAR-2 relax rat gastric artery via multiple mechanisms","volume":"75","author":"Kawabata","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.peptides.2009.11.026_bib16","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0022-3565(24)34971-7","article-title":"Heterogeneity of endothelium-dependent vasodilation in pressurized cerebral and small mesenteric resistance arteries of the rat","volume":"290","author":"Lagaud","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2009.11.026_bib17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1160\/TH07-08-0481","article-title":"Thrombin and protease-activated receptors (PARs) in atherothrombosis","volume":"99","author":"Martorell","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.peptides.2009.11.026_bib18","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.peptides.2009.06.014","article-title":"Mechanisms underlying enhanced vasorelaxant response to protease-activated receptor 2-activating peptide in type 2 diabetic Goto-Kakizaki rat mesenteric artery","volume":"30","author":"Matsumoto","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2009.11.026_bib19","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.2174\/1381612043383656","article-title":"Proteinase-activated Receptor 2 (PAR2): a challenging new target for treatment of vascular diseases","volume":"10","author":"McGuire","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.peptides.2009.11.026_bib20","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1124\/jpet.103.064584","article-title":"2-furoyl-LIGRLO-amide: a potent and selective proteinase-activated receptor 2 agonist","volume":"309","author":"McGuire","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2009.11.026_bib21","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00424-007-0226-2","article-title":"Persistence of PAR-2 vasodilation despite endothelial dysfunction in BPH\/2 hypertensive mice","volume":"454","author":"McGuire","year":"2007","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.peptides.2009.11.026_bib22","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1161\/01.STR.0000169929.66497.73","article-title":"Possible role for K+ in endothelium-derived hyperpolarizing factor-linked dilation in rat middle cerebral artery","volume":"36","author":"McNeish","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.peptides.2009.11.026_bib23","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1161\/01.STR.0000217307.71231.43","article-title":"Evidence for involvement of both IKCa and SKCa channels in hyperpolarizing responses of the rat middle cerebral artery","volume":"37","author":"McNiesh","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.peptides.2009.11.026_bib24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/sj.bjp.0707240","article-title":"Thromboxane A2 inhibition of SKCa after NO synthase block in rat middle cerebral artery","volume":"151","author":"McNeish","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.peptides.2009.11.026_bib25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/jcp.2003.015156","article-title":"Evidence that protease activated receptor 2 expression is enhanced in human coronary atherosclerotic lesions","volume":"57","author":"Napoli","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.peptides.2009.11.026_bib26","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1089\/08977150152693746","article-title":"Role of bradykinin B2 receptors in the formation of vasogenic brain edema in rats","volume":"18","author":"Plesnila","year":"2001","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.peptides.2009.11.026_bib27","doi-asserted-by":"crossref","first-page":"S263","DOI":"10.1038\/sj.bjp.0707507","article-title":"Proteinases and signaling: pathophysiological and therapeutic implications via PARs and more","volume":"153","author":"Ramachandran","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.peptides.2009.11.026_bib28","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1161\/01.ATV.0000184770.01494.2e","article-title":"Proteinase-activated receptor-2 mediates arterial vasodilation in diabetes","volume":"25","author":"Roviezzo","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.peptides.2009.11.026_bib29","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/jcb.20870","article-title":"Carbenoxolone inhibits junctional transfer and upregulates connexin 43 expression by a protein kinase A-dependent pathway","volume":"98","author":"Sagar","year":"2006","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.peptides.2009.11.026_bib30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-4615-4711-2_11","article-title":"Mediators of cerebral edema","volume":"474","author":"Schilling","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.peptides.2009.11.026_bib31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00127893-200201000-00003","article-title":"Hyperfusion encephalopathies: hypertensive encephalopathy and related conditions","volume":"8","author":"Schwartz","year":"2002","journal-title":"Neurologist"},{"issue":"1","key":"10.1016\/j.peptides.2009.11.026_bib32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jnr.20219","article-title":"Analysis of pathological events at the onset of brain damage in stroke-prone rats: a proteomics and magnetic resonance imaging approach","volume":"78","author":"Sironi","year":"2004","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.peptides.2009.11.026_bib33","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1161\/01.STR.20.9.1212","article-title":"Hemorrhagic stroke development in spontaneously hypertensive rats fed a North American, Japanese-style diet","volume":"20","author":"Smeda","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.peptides.2009.11.026_bib34","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1097\/00004872-199917120-00006","article-title":"Stroke-prone spontaneously hypertensive rats lose their ability to auto-regulate cerebral blood flow","volume":"17","author":"Smeda","year":"1999","journal-title":"J Hypertens"},{"key":"10.1016\/j.peptides.2009.11.026_bib35","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0022-3565(24)35140-7","article-title":"Effect of poststroke captopril treatment on mortality associated with hemorrhagic stroke in stroke-prone rats","volume":"291","author":"Smeda","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2009.11.026_bib36","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/01.STR.31.3.751","article-title":"Electromechanical alterations in the cerebrovasculature of stroke-prone rats","volume":"31","author":"Smeda","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.peptides.2009.11.026_bib37","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/01.STR.30.9.1933","article-title":"Evidence for selective effects of chronic hypertension on cerebral artery vasodilation of protease-activated receptor-activated receptor-2 activation","volume":"30","author":"Sobey","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.peptides.2009.11.026_bib38","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/sj.bjp.0705415","article-title":"Bradykinin B2 receptor antagonism: a new direction for acute stroke therapy?","volume":"139","author":"Sobey","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.peptides.2009.11.026_bib39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1540\/jsmr.40.125","article-title":"Maxi K channel roles in blood vessel relaxations induced by endothelium-derived relaxing factors and their molecular mechanisms","volume":"40","author":"Tanaka","year":"2004","journal-title":"J Smooth Muscle Res"},{"key":"10.1016\/j.peptides.2009.11.026_bib40","first-page":"H335","article-title":"Glycyrrhetinic derivatives inhibit hyperpolarization in endothelial cells of guinea pig and rat arteries","volume":"282","author":"Tare","year":"2002","journal-title":"Am J Physiol"},{"key":"10.1016\/j.peptides.2009.11.026_bib41","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.3181\/00379727-133-34695","article-title":"Simple method for quantitation of enhanced vascular permeability","volume":"133","author":"Ukaka","year":"1970","journal-title":"Proc Soc Exp Biol Med"},{"issue":"5","key":"10.1016\/j.peptides.2009.11.026_bib42","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/sj.bjp.0702634","article-title":"Characterization of the inflammatory response to proteinases-activated receptor-2 (PAR2)-activating peptides in the rat paw","volume":"127","author":"Vergnolle","year":"1999","journal-title":"Br J Pharmacol"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978109005178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978109005178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:20:58Z","timestamp":1759310458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978109005178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0196978109005178"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2009.11.026","relation":{},"ISSN":["0196-9781"],"issn-type":[{"type":"print","value":"0196-9781"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protease-activated receptor 2 and bradykinin-mediated vasodilation in the cerebral arteries of stroke-prone rats","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2009.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}